Previous 10 | Next 10 |
home / stock / glpgf / glpgf news
Summary David Einhorn's 13F stock portfolio value decreased from $1.57B to $1.29B this quarter. Greenlight increased Atlas Air Worldwide, Kyndryl Holdings, and Victoria’s Secret while decreasing Teck Resources, Change Healthcare, Chemours, and International Seaways. They al...
Galapagos ( OTCPK:GLPGF ) received a transparency notification from FMR LLC, who notified that it holds 3,710,782 of Galapagos’ voting rights. FMR controls investment funds Fidelity Management & Research Company, FIAM Holdings, Fidelity Management Trust Company and ...
Galapagos NV (GLPG) Q2 2022 Earnings Conference Call August 5, 2022 08:00 ET Company Participants Sofie Van Gijsel - Senior Director of Investor Relations Paul Stoffels - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer ...
Mechelen, Belgium-based biotech Galapagos (NASDAQ:GLPG) (OTC:GLPGF) has agreed to acquire CellPoint, a privately held developer of point-of-care CAR-T therapies and AboundBio, a developer of antibody-based biological therapeutics for cancers. Per the terms, Galapagos (GLPG) is expected to acq...
Takeda's total debt was $35,698.6 million, down 22.1% from the previous year. Takeda Pharmaceutical has a dividend yield of 5.15%, and Gilead Sciences has a dividend yield of 4.53%. Gilead's key HIV drug is beginning to feel increased competition from ViiV Healthcare's drug. T...
Reviewing its coverage on biotechs with negative enterprise values, Morgan Stanley says that the number of companies on the list with potential catalysts in 2022 has increased to 27 in May from 20 previously. Adding market capitalization to total debt and deducting cash and cash equivalents, ...
David Einhorn's 13F stock portfolio value decreased from $1.75B to $1.57B this quarter. Greenlight increased Chemours, Warner Bros. Discovery, Resideo, LivaNova, Kyndryl, and PLBY while dropping Jack in the Box and EchoStar. They also added Southwestern Energy, Weatherford plc, Intern...
The following slide deck was published by Galapagos NV in conjunction with their 2022 Q1 earnings call. For further details see: Galapagos NV 2022 Q1 - Results - Earnings Call Presentation
Galapagos NV (GLPG) Q1 2022 Results Conference Call May 6, 2022 08:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Paul Stoffels - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Of...
David Einhorn's 13F stock portfolio value increased from $1.49B to $1.75B this quarter. Greenlight increased Capri Holdings, ODP Group, Livanova, & Victoria’s Secret while reducing Twitter, Concentrix, & EchoStar. They also added Global Payments while dropping AerCap an...
News, Short Squeeze, Breakout and More Instantly...
Galapagos Genomics Ord Company Name:
GLPGF Stock Symbol:
OTCMKTS Market:
Galapagos Genomics Ord Website:
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual Euro...
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’ decentralized manufacturing platform in patients with head & neck cancer Uza-cel has shown enc...
BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centers Collaboration enables rapid deployment of Galapagos' decentralized CAR-T platform across the U.S., improving patient access ...